Eve Health Group Limited · ASX:EVE

Eve Health — Shareholder Meeting (November 2020)

20 slides from Eve Health's shareholder meeting presentation, Nov 26, 2020

  1. Slide 1: AGM Presentation 26 November 2020

    For personal use only AGM PRESENTATION 26 NOVEMBER 2020

  2. Slide 2: Key Milestones: Achievements

    KEY KEY MILESTONES ACHIEVEMENTS For personal use only BRAND $9.3M TOP 20 PROBIOTIC RECORD MELUKA NEW FURTHER 13% STRONG CASH PLACEMENT Record sales in US Amazon CONCENTRATE HALF YEAR IN TAIWAN CHINESE EXPANSION POSITION REFRESH YIELD Meluka Australia brand COMPLETION during COVID lockdowns. LAUNCH

  3. Slide 3: Key Milestones: Appointments

    KEY KEY MILESTONES APPOINTMENTS For personal use only NEW APPOINTMENTS FARM NON-EXECUTIVE MARKETING BRAND MANAGER DIRECTORS MANAGER MANAGER (JENBROOK) Carlos Jin (Finance) Stephanie Yip Rebecca Bak Jesse Redhead Joalin Chou (Marketing) (Jun 2020) (Oct 2020) (Nov 2019) (Jan 2020) MANAGING CHIEF CHIEF

  4. Slide 4: Distribution & Sales

    For personal use only DISTRIBUTION & SALES

  5. Slide 5: Key Markets

    KEY MARKETS For personal use only UK (2021) CANADA GERMANY (2021) USA CHINA JAPAN (YANDI BIOTECH) (2021) TAIWAN (AIFYA) ESTABLISHED MARKET SINGAPORE (2021) FUTURE MARKET AUSTRALIA | 05

  6. Slide 6: Current Distribution – Expansion Plans

    CURRENT DISTRIBUTION – EXPANSION PLANS For personal use only CHINA TAIWAN USA AUSTRALIA CANADA Naturally Australian Products (NAP), The Fair Traders Distribution Inc. (49% EVE owned) - bulk oil sales, (NSW) branded Meluka Australia products DISTRIBUTOR Yandi Biotech AIFYA International Group Amazon

  7. Slide 7: Emerging Distribution: Online Distribution Model for New Markets

    EMERGING DISTRIBUTION ONLINE DISTRIBUTION MODEL FOR NEW MARKETS For personal use only • One of the world’s largest online retailers is Amazon.com. The platform forms a key part of Meluka Australia’s online distribution model and acts as a gateway to enter our branded products into new markets (exclu

  8. Slide 8: Emerging Distribution

    EMERGING DISTRIBUTION For personal use only JAPAN SINGAPORE UK GERMANY Amazon Amazon Amazon CHANNEL Amazon Distributor Distributor Distributor (to be determined) (to be determined) (to be determined) *INITIAL PRODUCT/ Honey Range Honey Range Honey Range Honey Range RANGE Probiotic Concentrate ROLL O

  9. Slide 9: Product Portfolio

    For personal use only PRODUCT PORTFOLIO

  10. Slide 10: Product Portfolio

    PRODUCT PORTFOLIO For personal use only RAW HONEY RANGE ESSENTIAL OIL RAW HONEY PROBIOTIC CONCENTRATE RANGE Meluka Australia premium certified Meluka Australia premium Tea Tree Essential Oil. organic raw honey products that are Bulk sales of Australian native oils via subsidiary Meluka Australia pre

  11. Slide 11: Future Product Releases

    FUTURE PRODUCT RELEASES For personal use only FORECASTED NEW PRODUCT RELEASES OVER THE NEXT 18 MONTHS 2021 2022 Q3 Q4 Q1 Q2 Q3 RAW HONEY INFUSED WITH ARTISANAL GOURMET COLLAGEN PROBIOTIC ARTISANAL PREMIUM CONCENTRATE ESSENTIAL OIL RANGE APPLE CIDER VINEGAR RAW HONEY RAW HONEY Utilising the benefits

  12. Slide 12: CSR and R&D

    CSR AND R&D For personal use only CORPORATE SOCIAL RESEARCH & RESPONSIBILITY DEVELOPMENT • Maintaining the highest corporate governance standards. Research & development are a key part of maintaining our uniqueness in the industry. Future initiatives include: • 2020 collaboration to produce a bushfi

  13. Slide 13: For personal use only

    For personal use only CORPORATE UPDATE

  14. Slide 14: Corporate Performance: Share Price Performance

    CORPORATE PERFORMANCE For personal use only SHARE PRICE PERFORMANCE 0.014 0.012 0.01 100% SHARE PRICE $ FR AGM 19 0.008 Share price performance improving 0.006 with expansion of distribution channels and product ranges increasing 0.004 0.002 0 Nov-2019 Dec-2019 Jan-2020 Feb-2020 Mar-2020 Apr-2020 Ma

  15. Slide 15: Corporate Performance: Group Revenue and Cash Position

    CORPORATE PERFORMANCE For personal use only GROUP REVENUE CASH POSITION 2.5 7 2.1 6.2 CLOSING CASH POSITION $M 6 5.4 2 5.1 1.7 5 REVENUE $M 1.5 1.4 4 3 1 0.73 1.8 2 0.5 1 0 0 Dec-19 Mar-20 Jun-20 Sep-20 Dec-19 Mar-20 Jun-20 Sep-20 QUARTER QUARTER • Four quarters of continuous sales growth. • Decreas

  16. Slide 16: Sales Composition

    SALES COMPOSITION For personal use only SALES BY CATEGORY SALES BY REGION SALES BY CHANNEL HONEY D I S T R I B U T O R 15% 16% D I R E C T AUSTRALIA T O C O N S U M E R 29% 7% C O N T R A C T M A N U F A C T U R I N G 16% BULK OILS USA WHOLESALE 67% 56% 78% B R A N D E D O I L S 6% O T H E R 1% C H

  17. Slide 17: Corporate Overview: Capital Structure

    CORPORATE OVERVIEW For personal use only CAPITAL STRUCTURE ORDINARY SHARES 3,843,141,890 EVERHONEY OPTIONS/RIGHTS 135,866,665 17% MARKET CAP AUD $38M EV AUD $33M OTHER HONG KONG SHAREHOLDERS JUSHENG 45% KEY SHAREHOLDERS 13% EVERHONEY 17% HONG KONG JUSHENG 13% DIR E C TORS & MANAGE ME NT 8% DIRECTORS

  18. Slide 18: Exciting Outlook

    EXCITING OUTLOOK For personal use only • Expansion of sales in key markets - China and US. • New regions opening up – UK, Germany, Japan. • New product launches – additions to current ranges. • Growing awareness and demand for natural products to aid building of immunity and general health and welln

  19. Slide 19: Important Information

    IMPORTANT INFORMATION For personal use only This presentation has been prepared by EVE Investments Limited (“EVE”) to assist in informing interested parties about the Company and its progress. It should not be considered as an offer or invitation to subscribe for or purchase any securities in EVE or

  20. Slide 20: For personal use only

    For personal use only

Eve Health Group — Shareholder Meeting (November 2020) on 6ix